ATHE - Alterity Therapeutics Sotuvga nisbatan narx
Parkinson kasalligiga qarshi dori vositasi uchun II bosqich sinovlarining yakunlanishi Alterity Therapeutics (ATHE) kompaniyasi uchun asosiy drayver bo'ladi, bunda joriy metrika qiymati 2.20 ni tashkil etadi. P/S ko'rsatkichining tebranishlari daromadlilikning yo'qligi fonida bozor kutganlarini aks ettiradi. Alterity Therapeutics (ATHE) bioetik tamoyillarni joriy qilmoqda va kimyoviy chiqindilarni minimallashtirmoqda. Dori vositalarini klinikalarga tashish paytida qat'iy harorat nazorati orqali bemorlar xavfsizligi kafolatlanadi.
Alterity Therapeutics (ATHE) kompaniyasining tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi statistikasi:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Alterity Therapeutics|ATHE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati alteritytherapeutics.com|ATHE - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Alterity Therapeutics Ltd|ATHE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Alterity Therapeutics|Kritik likvidlik koeffitsiyenti alteritytherapeutics.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ATHE - Sof foyda|Kutilayotgan sof foyda Alterity Therapeutics|ATHE - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori alteritytherapeutics.com|ATHE - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Alterity Therapeutics Ltd|ATHE - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Alterity Therapeutics|ATHE - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi alteritytherapeutics.com|ATHE - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Alterity Therapeutics
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning fundamental tahlili:Alterity Therapeutics Ltd., ATHE
Portfelimni yuqori sifatli aktivlar bilan diversifikatsiya qilish uchun men yillik tushumga nisbatan bozor kapitalizatsiyasi bahosidan foydalanaman. Ushbu ko'rsatkich sotuvlarning bir dollari narxini o'lchab, biznes uchun to'langan premium miqdorini aniqlaydi. Miya degeneratsiyasi dori vositalari uchun eksklyuziv patentlarga ega bo'lgan Alterity Therapeutics (ATHE) uchun ushbu hisob-kitob kelgusidagi R&D muvaffaqiyatlariga bo'lgan bozor kutuvlarini aks ettiradi. 2.20 miqdoridagi joriy narx-sotuvlar nisbati investitsiya strategiyasini o'z vaqtida tuzatish imkonini beradi.
Raqobatdosh kompaniyalar
Kapitalizatsiyaning sotish hajmiga nisbati BIIB|Neurocrine Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Regencell Bioscience Ltd (RGC) - Sotuvga nisbatan narx|AXSM: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE (Xenon Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|VKTX: Kapitalizatsiyaning sotish hajmiga nisbati|SUPN (Supernus) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|HRMY - Sotuvga nisbatan narx|Narxning daromadga nisbati Biohaven Ltd. BHVN|Bozor kapitallashuvining daromadga nisbati AMLX|Trevi Therapeutics, Inc. - P/S multiplikatori|PRAX - P/S multiplikatori|Anavex Corp (AVXL) - Narxning daromadga nisbati|Narxning sotuvga nisbati CBLL (CeriBell EEG)|PRTA (Prothena Biosciences) - P/S multiplikatori|Sotuvga nisbatan narx Alector Therapeutics ALEC|Kapitalizatsiyaning daromadga nisbati ANNX (Annexon)|P/S multiplikatori omeros.com (OMER)|Neurogene Corp - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati ACIU (AC Immune Inc)|Voyager Therapeutics - P/S multiplikatori|Narx/daromad koeffitsiyenti neumoratx.com NMRA|SCLX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tevogen Bio Holdings Inc.|Narxning daromadga nisbati Alpha Cognition Inc|Cognition Therapeutics Inc. (CGTX) - Narx/daromad koeffitsiyenti|P/S multiplikatori IKT|P/S multiplikatori cassavasciences.com (SAVA)|Assertio - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati OVID (Ovid Therapeutics Inc.)|ABOS: P/S multiplikatori|Sotuvga nisbatan narx cervomed.com (CRVO)|Narxning daromadga nisbati Clene Inc|Kapitalizatsiya va daromad nisbati PEPG (PepGen Corp)|P/S multiplikatori JUNS|RLMD - Sotuvga nisbatan narx|Annovis Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Grace Therapeutics Inc GRCE|AIFF - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KLTO (Klotho Neurosciences Inc)|neurosense-tx.com (NRSN) - Narxning daromadga nisbati|Sotuvga nisbatan narx Reviva Pharmaceuticals, Inc. (RVPH)|MTVA (MetaVia Inc.) - P/S multiplikatori|P/S multiplikatori neuraxis.com|Narxning daromadga nisbati Helius Medical (HSDT)|Narxning daromadga nisbati PASG (passagebio.com)|Neuphoria Therapeutics - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati NERV (Minerva)|Athira Pharma, Inc. - P/S multiplikatori|Sotuvga nisbatan narx addextherapeutics.com|alzamend.com (ALZN) - Narxning daromadga nisbati|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining daromadga nisbati|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Pasithea (KTTA) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati ATXI|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Cara Therapeutics Inc. (CARA) - Sotuvga nisbatan narx|CHRO: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ELYM (Eliem Therapeutics)|ITCI (intracellulartherapies.com) - Kapitalizatsiyaning daromadga nisbati|LBPH: Kapitalizatsiyaning sotish hajmiga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE - Sotuvga nisbatan narx|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|Bozor kapitallashuvining daromadga nisbati TRVN|Vigil Neuro - P/S multiplikatori|WENA - P/S multiplikatori|Cerevel (CERE) - Narxning daromadga nisbati
